Philips NV

PHIA

NL0000009538

Advanced Medical Equipment & Technology

Market Closed - Euronext Amsterdam Other stock markets 11:35:28 2024-05-10 am EDT			5-day change	1st Jan Change
24.88 ^EUR	+1.26%		-0.64%	+18.00%

May. 09	European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	MT
May. 07	PHILIPS : Jefferies remains negative, but raises its target	CF

PHILIPS NV : Gets a Buy rating from Barclays

October 27, 2021 at 07:56 am EDT

Analyst Hassan Al-Wakeel from Barclays research considers the stock attractive and recommends it with a Buy rating. The target price has been modified and is now set at EUR 52 compared to EUR 53.

Latest news about Philips NV

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	May. 09	MT
PHILIPS : Jefferies remains negative, but raises its target	May. 07	CF
PHILIPS NV : Jefferies remains a Sell rating	May. 07	ZD
Elekta to Buy Philips Healthcare's Treatment Planning Patent Portfolio	May. 03	MT
PHILIPS NV : DZ Bank reiterates its Neutral rating	May. 02	ZD
Moody's Affirms Royal Philips' Rating, Upgrades Outlook on Enhanced Performance	May. 02	MT
UBS Upgrades Koninklijke Philips to Neutral From Sell	Apr. 30	MT
PHILIPS : Deutsche Bank upgrades recommendation to 'hold	Apr. 30	CF
PHILIPS NV : Barclays reiterates its Buy rating	Apr. 30	ZD
PHILIPS NV : Deutsche Bank reaffirms its Neutral rating	Apr. 30	ZD
PHILIPS : UBS raises its recommendation	Apr. 30	CF
PHILIPS NV : Goldman Sachs maintains a Buy rating	Apr. 30	ZD
PHILIPS NV : Deutsche Bank withdraws its Sell rating	Apr. 30	ZD
PHILIPS NV : UBS from Sell to Neutral	Apr. 30	ZD
PHILIPS NV : JP Morgan from Sell to Neutral	Apr. 30	ZD
ROYAL PHILIPS : The Dutch giant now poised for much better times	Apr. 29
PHILIPS NV : Barclays remains its Buy rating	Apr. 29	ZD
ROYAL PHILIPS : Litigation uncertainty no longer an overhang; Q1 profitability beat	Apr. 29
Tech Rally Subsides as US Equity Futures Waver Pre-Bell	Apr. 29	MT
Top Premarket Gainers	Apr. 29	MT
PHILIPS NV : UBS reiterates its Sell rating	Apr. 29	ZD
Philips Settles US Sleep Therapy Litigation for $1.1 Billion; Reaffirms 2024 Comparable Sales Outlook	Apr. 29	MT
European shares hit two-week high; inflation data, Fed meeting in focus	Apr. 29	RE
PHILIPS NV : Receives a Buy rating from Goldman Sachs	Apr. 29	ZD
Transcript : Koninklijke Philips N.V., Q1 2024 Earnings Call, Apr 29, 2024	Apr. 29

Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-13 - UBS Best of Europe Conference

Related indices

STOXX EUROPE 600 (EUR) , AEX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ROYAL PHILIPS : The Dutch giant now poised for much better times

April 29, 2024 at 01:48 pm EDT

Philips NV : The sleep apnea case makes a brutal comeback

October 06, 2023 at 05:20 am EDT

Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO

September 29, 2023 at 10:33 am EDT

More Strategies

Ratings for Philips NV

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

24.88 EUR

Average target price

25.11 EUR

Spread / Average Target

+0.91%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
PHILIPS NV	+18.00%	24.23B
THERMO FISHER SCIENTIFIC	+11.73%	226B
DANAHER CORPORATION	+9.53%	188B
INTUITIVE SURGICAL, INC.	+14.63%	137B
BOSTON SCIENTIFIC CORPORATION	+27.47%	108B
SIEMENS HEALTHINEERS AG	-0.04%	63.19B
EDWARDS LIFESCIENCES CORPORATION	+13.73%	52.26B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.86%	51B
AGILENT TECHNOLOGIES, INC.	+7.72%	43.89B
GE HEALTHCARE TECHNOLOGIES INC.	+7.86%	38.07B

Other Advanced Medical Equipment & Technology

Philips NV

Equities

PHIA

NL0000009538

Advanced Medical Equipment & Technology

PHILIPS NV : Gets a Buy rating from Barclays

Latest news about Philips NV

Chart Philips NV

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Philips NV

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology